We are live on ! Find out more
FBRX icon

Forte Biosciences

52 hedge funds and large institutions have $6.83M invested in Forte Biosciences in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,500% more call options, than puts

Call options by funds: $104K | Put options by funds: $4K

0% more funds holding

Funds holding: 5252 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.4% less ownership

Funds ownership: 1.46%1.07% (-0.4%)

46% less capital invested

Capital invested by funds: $12.6M → $6.83M (-$5.8M)

68% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 22

Holders
52
Holders Change
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
22
Closed
9
Calls
$104K
Puts
$4K
Net Calls
+$100K
Net Calls Change
-$122K
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$28K -$8.1K -214 -22%
HSBC Holdings
27
HSBC Holdings
United Kingdom
$19K
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$17K
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$14K -$189 -5 -1%
TRCT
30
Tower Research Capital (TRC)
New York
$13K +$6.43K +170 +92%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$8K -$1.36K -36 -15%
AIG
32
American International Group
New York
$8K -$605 -16 -7%
JP Morgan Chase
33
JP Morgan Chase
New York
$8K +$1.29K +34 +19%
CG
34
Cutler Group
California
$6K -$3.18K -84 -32%
Federated Hermes
35
Federated Hermes
Pennsylvania
$4K +$1.93K +51 +77%
UBS Group
36
UBS Group
Switzerland
$3K -$14.2K -374 -81%
AB
37
Amalgamated Bank
New York
$3K +$2.91K +77 New
AF
38
Amalgamated Financial
New York
$3K +$2.91K +77 New
Barclays
39
Barclays
United Kingdom
$3K +$3.75K +99 New
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$2K -$2.61K -69 -57%
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$2K -$114 -3 -6%
Legal & General Group
42
Legal & General Group
United Kingdom
$2K
Citigroup
43
Citigroup
New York
$1K -$2.88K -76 -75%
AIP
44
Ameritas Investment Partners
Nebraska
$1K
Osaic Holdings
45
Osaic Holdings
Arizona
$1K +$530 +14 +74%
TWC
46
TD Waterhouse Canada
Ontario, Canada
$151
Millennium Management
47
Millennium Management
New York
-$601K -11,240 Closed
AFM
48
Anson Funds Management
Texas
-$292K -5,463 Closed
XT
49
XTX Topco
Cayman Islands
-$58K -1,083 Closed
DU
50
Delphia (USA)
Ontario, Canada
-$33K -610 Closed

FBRX Hedge Fund Activity: Q1 2022 in Review

52 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2022, worth a combined $6.83M — down 46% from $12.6M a quarter earlier.

Fund positioning in FBRX was balanced in Q1 2022: 9 funds opened new positions, 9 closed out, 7 added to existing stakes and 22 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $287K. The largest seller was Morgan Stanley, cutting an estimated $1.02M.

  • 52 institutional investors held Forte Biosciences (FBRX) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $6.83M of Forte Biosciences stock for Q1 2022, down 46% quarter-over-quarter.
  • 9 funds opened new Forte Biosciences positions in Q1 2022 and 9 closed out, a net change of 0 holders.
  • The largest Forte Biosciences buyer in Q1 2022 was Renaissance Technologies, an estimated $287K added.
  • The largest Forte Biosciences seller in Q1 2022 was Morgan Stanley, an estimated $1.02M sold.

Based on aggregated 13F filings for Q1 2022.